Flavone-Based Novel Antidiabetic and Antidyslipidemic Agents

Journal of Medicinal Chemistry
2012.0

Abstract

The hybrid congeners 62-90 of 6- and 7-hydroxyflavones with aminopropanol have been synthesized and evaluated for their antidiabetic activity in sucrose-challenged low-dosed streptozotocin (STZ)-induced diabetic rats and db/db mice. The optical enantiomers 70a, 70b, 90a, and 90b of two congeners 70 and 90 exhibiting consistent antidiabetic and antidyslipidemic activities were also prepared, and their antidiabetic activity results indicate its association mainly with S isomers. These compounds also lower cholesterol and TG profiles while improving high-density lipoprotein cholesterol to CHOL ratio in db/db mice. The bioavailability of compound 70 and its isomer varies between 27 and 29% whereas that of the more polar compound 90a is poor as determined in rat by oral and intraperitoneal administrations.

Knowledge Graph

Similar Paper

Flavone-Based Novel Antidiabetic and Antidyslipidemic Agents
Journal of Medicinal Chemistry 2012.0
Design, synthesis, and evaluation of benzofuran-based chromenochalcones for antihyperglycemic and antidyslipidemic activities
RSC Medicinal Chemistry 2023.0
A comparative study of flavonoid analogues on streptozotocin–nicotinamide induced diabetic rats: Quercetin as a potential antidiabetic agent acting via 11β-Hydroxysteroid dehydrogenase type 1 inhibition
European Journal of Medicinal Chemistry 2010.0
Total synthesis of 8-(6″-umbelliferyl)-apigenin and its analogs as anti-diabetic reagents
European Journal of Medicinal Chemistry 2016.0
Synthesis of propiophenone derivatives as new class of antidiabetic agents reducing body weight in db/db mice
Bioorganic & Medicinal Chemistry 2012.0
Chalcone based aryloxypropanolamines as potential antihyperglycemic agents
Bioorganic & Medicinal Chemistry Letters 2007.0
Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives
Bioorganic & Medicinal Chemistry Letters 2018.0
Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents
European Journal of Medicinal Chemistry 2013.0
Synthesis and biological activity of some new flavonyl-2,4-thiazolidinediones
Bioorganic & Medicinal Chemistry 2008.0
Synthesis of novel triterpenoid (lupeol) derivatives and their in vivo antihyperglycemic and antidyslipidemic activity
Bioorganic & Medicinal Chemistry Letters 2009.0